Aevi Genomic Medicine Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 14
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $23.5M
Latest Deal Amount

Aevi Genomic Medicine General Information

Description

Medgenics is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves the usage of individual's genomic information to decide upon clinical care. This medical discipline is used in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Medgenics' partner is the Center for Applied Genomics at the Children's Hospital of Philadelphia, with which it works to develop drugs by implementing genomics medicine.

Contact Information

Website
www.aevigenomics.com
Formerly Known As
Biogenics, MedGenics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Avalo Therapeutics
Primary Office
  • 435 Devon Park Drive
  • Suite 715
  • Wayne, PA 19087
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aevi Genomic Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 03-Feb-2020 $23.5M 000.00 000.00 Completed Generating Revenue
11. PIPE 17-Oct-2017 0000 000.00 Completed Generating Revenue
10. 2PO 24-Jun-2016 0000 000.00 Completed Generating Revenue
9. PIPE 19-Jun-2012 00.00 000.00 Completed Generating Revenue
8. Debt - General 04-Nov-2010 000 0000 Completed Generating Revenue
7. PIPE 26-May-2010 00000 0000 Completed Generating Revenue
6. Debt - General 23-Jun-2009 00000 000.00 Completed Generating Revenue
5. IPO 04-Dec-2007 00.000 000.00 000.00 Completed Generating Revenue
4. Angel (individual) 19-Apr-2006 $27K $19.6M Completed Startup
3. Early Stage VC (Series B) 25-Apr-2003 $12.3M $19.5M 000.00 Completed Startup
To view Aevi Genomic Medicine’s complete valuation and funding history, request access »

Aevi Genomic Medicine Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B1 0,000,000 00.000000 00.00 00 00 00 00
Series B 0,000,000 00.000000 00.00 00 00 00 00 00.00
Series A1 4,224,339 $0.000100 $0.14 $1.71 $1.71 1x $1.71
Series A 4,224,339 $0.000100 $0.14 $1.71 $1.71 1x $1.71 26.99%
To view Aevi Genomic Medicine’s complete cap table history, request access »

Aevi Genomic Medicine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Medgenics is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves t
Drug Discovery
Wayne, PA
14 As of 2018
000.00
00.00 0000-00-00
000000&0 000.00

00000000

nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000000
Philadelphia, PA
0000
000 0000-00-00
0000000000 0 0000

00000000

or incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation u
0000 000000000
Wayne, PA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aevi Genomic Medicine Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Limelight Bio Formerly VC-backed Philadelphia, PA 0000 0000000000 0 0000
00000000 000000000 Venture Capital-Backed Wayne, PA 00 000.00 00000000000 000.00
00000 0000 0000000 Private Equity-Backed Irving, TX 0000 00.00 0000000 0000 00.00
000000000 00000000 Venture Capital-Backed San Diego, CA 0 000.00 000000000 000.00
000000000 Corporation Epalinges, Switzerland 0
You’re viewing 5 of 12 competitors. Get the full list »

Aevi Genomic Medicine Patents

  • 53

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Aevi Genomic Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190030128-A1 Compositions and methods for treatment of central nervous system diseases Abandoned 11-Jan-2016 00000000000
EP-3402531-A4 Compositions and methods for treatment of central nervous system diseases Withdrawn 11-Jan-2016 00000000000 0
EP-3402531-A1 Compositions and methods for treatment of central nervous system diseases Withdrawn 11-Jan-2016 00000000000
US-20160122713-A1 Genetically-modified micro-organ secreting a therapeutic peptide and methods of use thereof Abandoned 14-Oct-2014 0000000000 0
US-20150118187-A1 Micro-organs providing sustained delivery of a therapeutic polypeptide and methods of use thereof Abandoned 24-Oct-2013 A61K38/1816 0
To view Aevi Genomic Medicine’s complete patent history, request access »

Aevi Genomic Medicine Executive Team (13)

Name Title Board Seat Contact Info
Andrew Pearlman Ph.D Chief Executive Officer & Board Member
Marvin Garovoy Chief Medical Officer
Garry Neil MD Chief Scientific Officer
You’re viewing 3 of 13 executive team members. Get the full list »

Aevi Genomic Medicine Board Members (19)

Name Representing Role Since
Alastair Clemow Ph.D Self Board Member 000 0000
Andrew Pearlman Ph.D Aevi Genomic Medicine Chief Executive Officer & Board Member 000 0000
Eugene Bauer MD Self Board Member 000 0000
Isaac Blech Self Board Member 000 0000
Joel Kanter Self Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Aevi Genomic Medicine Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aevi Genomic Medicine Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alta Berkeley Venture Capital Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
Andrew Klopfer Angel (individual) Minority 000 0000 000000 0
CIBC Capital Markets Investment Bank Minority 000 0000 000000 0
Chicago Private Investments Other Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Aevi Genomic Medicine Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 09-Sep-2015 0000000000 00000 Drug Discovery 0000000 0
To view Aevi Genomic Medicine’s complete acquisitions history, request access »

Ready to get started?

Request a free trial